Literature DB >> 8814477

Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia.

G Putz1, C Hörmann, W Koller, G Schön.   

Abstract

A modified natural surfactant was administered to a patient with life-threatening adult respiratory distress syndrome caused by viral pneumonia. Subsequently, there was a marked improvement in gas exchange. In order to assess the mechanism for improved oxygenation, computed tomography of the lungs was done. Quantitative analysis of the scans taken before and after surfactant administration indicates that improvement in gas exchange was largely due to the expansion of underinflated and collapsed lung areas. Although this is a single case report, it provides insight into the possible beneficial effect of instilled surfactant in severe respiratory distress from viral pneumonia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8814477      PMCID: PMC7095348          DOI: 10.1007/bf01708102

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  9 in total

1.  [Biphasic positive airway pressure (BIPAP)--a new form of augmented ventilation].

Authors:  M Baum; H Benzer; C Putensen; W Koller; G Putz
Journal:  Anaesthesist       Date:  1989-09       Impact factor: 1.041

2.  Is it rational to treat pneumonia with exogenous surfactant?

Authors:  B Lachmann; D Gommers
Journal:  Eur Respir J       Date:  1993-11       Impact factor: 16.671

3.  Relationships between lung computed tomographic density, gas exchange, and PEEP in acute respiratory failure.

Authors:  L Gattinoni; A Pesenti; M Bombino; S Baglioni; M Rivolta; F Rossi; G Rossi; R Fumagalli; R Marcolin; D Mascheroni
Journal:  Anesthesiology       Date:  1988-12       Impact factor: 7.892

4.  Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome.

Authors:  R G Spragg; N Gilliard; P Richman; R M Smith; R D Hite; D Pappert; B Robertson; T Curstedt; D Strayer
Journal:  Chest       Date:  1994-01       Impact factor: 9.410

5.  Lung structure and function in different stages of severe adult respiratory distress syndrome.

Authors:  L Gattinoni; M Bombino; P Pelosi; A Lissoni; A Pesenti; R Fumagalli; M Tagliabue
Journal:  JAMA       Date:  1994-06-08       Impact factor: 56.272

6.  Immediate improvement in lung volume after exogenous surfactant: alveolar recruitment versus increased distention.

Authors:  L S Goldsmith; J S Greenspan; S D Rubenstein; M R Wolfson; T H Shaffer
Journal:  J Pediatr       Date:  1991-09       Impact factor: 4.406

7.  Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone.

Authors:  D Gommers; C Vilstrup; J A Bos; A Larsson; O Werner; E Hannappel; B Lachmann
Journal:  Crit Care Med       Date:  1993-04       Impact factor: 7.598

8.  Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome.

Authors:  J G Weg; R A Balk; R S Tharratt; S G Jenkinson; J B Shah; D Zaccardelli; J Horton; E N Pattishall
Journal:  JAMA       Date:  1994-11-09       Impact factor: 56.272

9.  Body position changes redistribute lung computed-tomographic density in patients with acute respiratory failure.

Authors:  L Gattinoni; P Pelosi; G Vitale; A Pesenti; L D'Andrea; D Mascheroni
Journal:  Anesthesiology       Date:  1991-01       Impact factor: 7.892

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.